Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient

MeSH terms

• Benzamides
• Carcinoma, Non-Small-Cell Lung / diagnosis
• Carcinoma, Non-Small-Cell Lung / drug therapy
• Carcinoma, Non-Small-Cell Lung / metabolism*
• Chemotherapy, Adjuvant
• Chordoma / drug therapy
• Chordoma / metabolism*
• Chordoma / pathology
• Disease Progression
• Humans
• Imatinib Mesylate
• In Situ Hybridization, Fluorescence / methods
• Lung Neoplasms / diagnosis
• Lung Neoplasms / drug therapy
• Lung Neoplasms / metabolism*
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy
• Neoplasm Recurrence, Local / metabolism
• Neoplasms, Second Primary / diagnosis
• Neoplasms, Second Primary / drug therapy
• Neoplasms, Second Primary / metabolism*
• Piperazines / pharmacology
• Piperazines / therapeutic use
• Proto-Oncogene Proteins c-kit / drug effects
• Proto-Oncogene Proteins c-kit / genetics
• Proto-Oncogene Proteins c-kit / metabolism*
• Pyrimidines / pharmacology
• Pyrimidines / therapeutic use
• Receptor, Platelet-Derived Growth Factor alpha / drug effects
• Receptor, Platelet-Derived Growth Factor alpha / genetics
• Receptor, Platelet-Derived Growth Factor alpha / metabolism*
• Receptor, Platelet-Derived Growth Factor beta / drug effects
• Receptor, Platelet-Derived Growth Factor beta / genetics
• Receptor, Platelet-Derived Growth Factor beta / metabolism*
• Sensitivity and Specificity